These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 308390)

  • 21. Immunobiological properties of 1-butanol-extracted cell surface antigens.
    LeGrue SJ; Allison JP; Macek CM; Pellis NR; Kahan BD
    Cancer Res; 1981 Oct; 41(10):3956-60. PubMed ID: 7026027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth.
    Calderwood MB; Forbes JT; Smith RT
    Br J Cancer; 1981 Apr; 43(4):505-16. PubMed ID: 6972224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the induction of contrasuppression by antisera against tumor-associated surface antigens on methylcholanthrene-induced sarcomas.
    Flood PM; DeLeo AB; Old LJ; Gershon RK
    Haematol Blood Transfus; 1983; 28():486-8. PubMed ID: 6222948
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 26. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytolytic antibodies to methylcholanthrene-induced sarcomas elicited by immunization of syngeneic mice.
    Merino F; Abeyounis CJ; Milgrom F
    Eur J Cancer (1965); 1979 Jun; 15(6):829-35. PubMed ID: 499271
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice.
    Engel AM; Svane IM; Rygaard J; Werdelin O
    Scand J Immunol; 1997 May; 45(5):463-70. PubMed ID: 9160088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of T-cell lines with inhibitory or stimulatory activity against syngeneic tumors in vivo. A preliminary report.
    Mulé JJ; Forstrom JW; George E; Hellström I; Hellström KE
    Int J Cancer; 1981 Nov; 28(5):611-4. PubMed ID: 6796530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antigenic competition on immune responses to tumors.
    Glasgow AH; Badger AM
    Ann N Y Acad Sci; 1976; 276():496-501. PubMed ID: 1071974
    [No Abstract]   [Full Text] [Related]  

  • 32. Discussion paper: in vitro augmentation of tumor immunity in a murine methylcholanthrene sarcoma system.
    Yarlott MA; McKhann CF
    Ann N Y Acad Sci; 1976; 277(00):533-40. PubMed ID: 187102
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
    Frbes JT; Nakaw Y; Smith RT
    J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunity to chemically induced rat sarcomas: study of the specificity of cytotoxic cells.
    Goguel AF; Nauciel C
    Ann Immunol (Paris); 1979; 130C(5):621-34. PubMed ID: 316679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro sensitivity of twom methylcholanthrene-induced murine sarcoma lines to humoral and cellular immune cytotoxicity.
    Bataillon G; Pross H; Klein G
    Int J Cancer; 1975 Aug; 16(2):255-65. PubMed ID: 1150353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of different T cells sets in the rejection of syngeneic chemically induced tumors.
    Shimizu K; Shen FW
    J Immunol; 1979 Mar; 122(3):1162-5. PubMed ID: 312820
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro activity of subpopulations of immune lymphocytes against murine sarcoma cells.
    Lamon EW; Wigzell H
    Transplantation; 1974 Oct; 18(4):368-71. PubMed ID: 4547517
    [No Abstract]   [Full Text] [Related]  

  • 40. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
    Ishikawa Y; Fukushima M; Sato T; Komaba M; Yagihashi H
    Tohoku J Exp Med; 1971 Feb; 103(2):195-201. PubMed ID: 5580594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.